Strategic Partnerships SWOG collaborates with multiple external research groups and industry partners (e.g., ECOG-ACRIN, BostonGene, Agendia, Paxman) to run trials and enhance capabilities, indicating strong cross-organizational collaboration potential for co-developed studies, data sharing, and technology integrations.

Public Funding Advantage As part of the NCI’s National Clinical Trials Network and funded by public sources, SWOG has a stable, government-backed research pipeline and demand for scalable services in protocol development, data management, and clinical trial administration.

Global and Diverse Network With more than 20,000 members across 46 states and eight other countries, SWOG offers extensive reach for multi-site trials, patient recruitment, and diverse data collection, presenting upsell opportunities in site networks, enrollment support, and centralized analytics.

Operational Excellence Distributed operations across major cancer centers (OHSU, University of Texas Health San Antonio, Fred Hutch/CAB) plus a dedicated data management center signal readiness for high-quality data services, biospecimen handling, and robust adverse event monitoring for potential vendor collaborations.

Growth Through Innovation Recent leadership appointments and new committees (Advanced Practice Provider and Nurse Scientist Committee) alongside ongoing collaborations in personalized medicine indicate opportunities to offer advanced training, digital health platforms, and AI-driven trial analytics to support evolving trial designs.